A3 adenosine receptor agonist potentiates natural killer cell activity.

International journal of oncology

Volumn 23, Issue 4, 2003, Pages 1245-1249

  Harish, Arie ^a   Hohana, Gil ^a   Fishman, Pnina ^a   Arnon, Oshra ^a   Bar Yehuda, Sara ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A3 RECEPTOR; CYCLIN D1; INTERLEUKIN 12; MYC PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; KINETICS; MELANOMA; METABOLISM; MOUSE; NATURAL KILLER CELL; SPLEEN; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; G0 PHASE; G1 PHASE; INTERLEUKIN-12; KILLER CELLS, NATURAL; KINETICS; MELANOMA; MICE; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ADENOSINE A3; SPLEEN;

EID: 3042613515     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.23.4.1245     Document Type: Article

References (0)